{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:40:33Z","timestamp":1790714433470,"version":"4.1.0"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with\n                    <jats:italic>Cunninghamella bertholletiae<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1128\/aac.00452-07","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T11:46:56Z","timestamp":1177415216000},"page":"2587-2590","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":249,"title":["In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents"],"prefix":"10.1128","volume":"51","author":[{"given":"Nikolaos G.","family":"Almyroudis","sequence":"first","affiliation":[{"name":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna A.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Fungus Testing Laboratory, Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette W.","family":"Fothergill","sequence":"additional","affiliation":[{"name":"Fungus Testing Laboratory, Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Fungus Testing Laboratory, Department of Pathology"},{"name":"Audie L. Murphy, South Texas Veterans Health Care System, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Kusne","sequence":"additional","affiliation":[{"name":"Mayo Clinic Arizona, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01496.x"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.327-330.2001"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.828-833.2002"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.917-921.2006"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg020"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1953-1959.2002"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3647-3650.2003"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3623-3626.2003"},{"key":"e_1_3_1_10_2","first-page":"297","year":"2003","unstructured":"Dromer, F., and M. R. McGinnis. 2003. Zygomycosis, p. 297-308. In E. J. Anaissie, M. R. McGinnis, and M. A. Pfaller (ed.), Clinical mycology, Churchill Livingstone, Philadelphia, PA.","journal-title":"Clinical mycology, Churchill Livingstone, Philadelphia, PA"},{"key":"e_1_3_1_11_2","first-page":"159","volume":"47","year":"2004","unstructured":"Eisen, D. P., and J. Robson. 2004. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis. Antimicrob. Agents Chemother.47:159-162.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01187-06"},{"key":"e_1_3_1_13_2","first-page":"895","year":"2002","unstructured":"Gonzalez, C. E., M. G. Rinaldi, and A. M. Sugar. 2002. Zygomycosis, p. 895-914. In R. C. Moellering, Jr., T. J. Walsh, and J. H. Rex (ed.), Infectious disease clinics of North America, W. B. Saunders Company, Philadelphia, PA.","journal-title":"Infectious disease clinics of North America"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.126-133.2006"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/313803"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/428780"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1480"},{"key":"e_1_3_1_18_2","unstructured":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi 2002"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01138473"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00246-0"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1032-1037.2002"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/432579"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-06"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2005.01132.x"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.830-832.2005"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.Supplement_1.S126"},{"key":"e_1_3_1_28_2","first-page":"2973","year":"2005","unstructured":"Sugar, A. M. 2005. Agents of mucormycosis and related species, p. 2973-2984. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 6th ed. Churchill Livingstone, Philadelphia, Pa.","journal-title":"Principles and practice of infectious diseases"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1581-1582.2002"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2310-2312.2002"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1086\/500212"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00452-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00452-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T14:25:01Z","timestamp":1645453501000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00452-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1128\/AAC.00452-07"],"URL":"https:\/\/doi.org\/10.1128\/aac.00452-07","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1092158.545539","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"2007-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}